LA LABResearch Reference Document
Compound Guide
Oxytocin — Neuropeptide Hormone
Quick Start
FDA Approved — Hospital Use Only (IV/IM, Obstetrics)
Oxytocin is FDA-approved as Pitocin for IV/IM administration in hospital obstetric settings — labour induction, postpartum haemorrhage, and uterine atony. Intranasal and subcutaneous administration are investigational (non-approved) routes. This guide covers the investigational research context. Do not confuse research preparations with Pitocin.
What It Is
Oxytocin is a 9-amino acid nonapeptide produced in the hypothalamus (PVN and SON nuclei) and released by the posterior pituitary. It mediates uterine contractions, lactation, and — as a neurotransmitter acting in limbic brain circuits — trust, social bonding, anxiety reduction, and aspects of social cognition. Often called "the bonding hormone."
Research Dosing (Intranasal)
Intranasal: 10–72 IU per session, divided into 2–4 sprays per nostril. The SOARS-B autism trial used up to 48 IU/day. Half-life intranasally: ~20 minutes for direct nasal effects, but downstream brain effects last hours. Note: 1 IU ≈ 2 mcg oxytocin. SubQ dosing (100–500 mcg) does not meaningfully cross the blood-brain barrier — central effects are primarily via intranasal delivery.
Regulatory Status
FDA-approved IV/IM (Pitocin) for obstetric use only — hospital-administered. Intranasal/SubQ are investigational. Not on WADA prohibited list. Research preparations (not Pitocin) used in investigational contexts. For research purposes only.
Dosing Protocols by Route
| Route | Dose | Timing | BBB Penetration | Context |
|---|---|---|---|---|
| Intranasal | 10–72 IU/session | 20–40 min before activity or test | Direct nasal-brain pathway | Central effects (social, cognitive) — primary research route |
| SubQ injection | 100–500 mcg | 20–30 min before | Minimal | Peripheral effects; limited central brain activity |
| IV/IM (Pitocin) | As per obstetric label | Hospital only | Not applicable | Approved use only; not for research settings outside hospitals |
IU to mcg Conversion
1 International Unit (IU) of oxytocin ≈ 2 mcg. A 5 mg research vial ≈ 2,500 IU. With 3.0 mL BAC water, concentration ≈ 833 IU/mL (≈1.67 mg/mL). For intranasal nasal spray, concentration of the spray solution and spray volume per actuation determine IU per spray — this varies by preparation.
Supplies & Reconstitution
Reconstitution & Dosing
LA LAB does not stock this as a standalone product, so vial-specific reconstitution and dosing figures are not provided here. This page is a research reference only. For compounds we carry, see our guides.
Reconstitution Steps
01
Warm the vial
Allow vial to reach room temperature from freezer before reconstitution.
02
Swab and draw
Alcohol swab both vial tops, air-dry. Draw required BAC water volume.
03
Inject along the wall
Let BAC water run slowly down the inside glass wall. Do not jet onto the powder.
04
Swirl gently
Swirl until clear. Oxytocin solution should be colourless. Do not shake.
05
Refrigerate
Store at 2–8°C for up to 30 days. Oxytocin is relatively stable in solution under refrigeration. Protect from light. Do not freeze after reconstitution.
Mechanism of Action
Oxytocin Receptor (OXTR)
Binds OXTR (a G-protein coupled receptor) throughout the brain (amygdala, nucleus accumbens, VTA, PFC) and periphery (uterus, breast, heart). Central OXTR activation mediates social bonding, trust, and anxiety modulation.
Amygdala Dampening
Reduces amygdala reactivity to threat and social stressors, studied in fMRI research. This is the proposed mechanism for reduced social anxiety and increased trust observed in controlled laboratory studies (Kirsch et al. 2005 meta-analysis).
Uterine Contraction (Peripheral)
The approved (Pitocin) mechanism: peripheral OXTR on smooth muscle drives uterine contractions for labour induction and haemorrhage control. This peripheral effect is relevant to safety — exogenous oxytocin in pregnancy can cause uterine hyperstimulation.
Short Plasma Half-life
IV half-life: 3–6 minutes. Intranasal effects persist 20 min to hours — the intranasal route produces direct olfactory-to-brain delivery, not through systemic circulation. This is why intranasal and IV oxytocin have very different effects profiles.
Key Human Research
| Study | Design | Key Finding |
|---|---|---|
| Kirsch et al. 2005 | RCT; intranasal; trust game paradigm | Intranasal oxytocin increased trust in a financial game vs placebo — landmark study |
| SOARS-B (NEJM 2021) | RCT; n=290; autism spectrum disorder; 24 weeks; up to 48 IU/day intranasal | NO significant difference in social responsiveness scale vs placebo — negative primary endpoint |
| Social anxiety studies | Multiple; intranasal; healthy volunteers | Reduced amygdala reactivity to threatening faces on fMRI; anxiety reduction not consistent across studies |
| Attachment theory research | Observational; intranasal studies | Enhanced mother-infant synchrony observed; effects context-dependent and not always replicable |
Replication Crisis in Oxytocin Research
The oxytocin research field has faced significant replication challenges. Many early findings (e.g. trust, generosity, eye contact effects) have not replicated in larger, pre-registered studies. Meta-analyses show highly heterogeneous effects across populations, doses, and contexts. The SOARS-B trial's negative result in autism is a key example. Interpret positive findings with caution.
Storage
| State | Temperature | Duration | Notes |
|---|---|---|---|
| Lyophilised (powder) | −20°C (freezer) | Up to 24 months | Protect from moisture; oxytocin is relatively stable lyophilised |
| Reconstituted (liquid) | 2–8°C (refrigerator) | Up to 30 days | More stable than most peptides once reconstituted; still protect from light |
| Short-term (travel) | <25°C | Up to 72 hours | Avoid heat and direct sunlight |
Disclaimer
This document is an educational research reference only. Oxytocin is FDA-approved only as Pitocin for IV/IM obstetric use in hospitals. Intranasal and SubQ routes are investigational. The research evidence base has significant replication issues. Do not confuse research preparations with Pitocin. By purchasing from LA LAB you confirm you are 18+ and that products are for research purposes only.